Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Filings indexed 1,059 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2026
Regulatory Filings
2026-05-13 English
8-K
Regulatory Filings
2026-05-06 English
10-Q - Sarepta Therapeutics, Inc. (0000873303) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-06 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-30 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-29 English
ARS
Annual Report
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.